A new trading day began on Monday, with Tango Therapeutics Inc (NASDAQ: TNGX) stock price down -3.59% from the previous day of trading, before settling in for the closing price of $3.06. TNGX’s price has ranged from $2.70 to $13.01 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 132.62% over the past five years. Meanwhile, its annual earnings per share averaged -11.20%. With a float of $49.52 million, this company’s outstanding shares have now reached $107.41 million.
Let’s look at the performance matrix of the company that is accounted for 140 employees. In terms of profitability, gross margin is 95.68%, operating margin of -322.0%, and the pretax margin is -283.95%.
Tango Therapeutics Inc (TNGX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tango Therapeutics Inc is 53.90%, while institutional ownership is 48.07%. The most recent insider transaction that took place on Nov 18 ’24, was worth 37,800. In this transaction Director of this company bought 10,000 shares at a rate of $3.78, taking the stock ownership to the 31,250 shares. Before that another transaction happened on Nov 14 ’24, when Company’s Director bought 10,000 for $3.62, making the entire transaction worth $36,200. This insider now owns 21,250 shares in total.
Tango Therapeutics Inc (TNGX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -11.20% per share during the next fiscal year.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
Here are Tango Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.17, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.43 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Tango Therapeutics Inc (NASDAQ: TNGX) saw its 5-day average volume 1.58 million, a positive change from its year-to-date volume of 1.02 million. As of the previous 9 days, the stock’s Stochastic %D was 18.60%. Additionally, its Average True Range was 0.38.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 2.68%, which indicates a significant decrease from 16.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 69.98% in the past 14 days, which was lower than the 110.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.77, while its 200-day Moving Average is $7.70. Nevertheless, the first resistance level for the watch stands at $3.18 in the near term. At $3.41, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.53. If the price goes on to break the first support level at $2.83, it is likely to go to the next support level at $2.71. The third support level lies at $2.48 if the price breaches the second support level.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
With a market capitalization of 340.23 million, the company has a total of 107,418K Shares Outstanding. Currently, annual sales are 36,530 K while annual income is -101,740 K. The company’s previous quarter sales were 11,610 K while its latest quarter income was -29,170 K.
